Benzinga's Top Upgrades - BlackRock (NYSE:BLK)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Morgan Stanley upgraded Vertex Pharmaceuticals Incorporated

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: VRTX) from Equal-weight to Overweight. The price target for Vertex Pharmaceuticals has been raised from $118 to $148. Vertex Pharmaceuticals shares closed at $107.23 on Thursday.Credit Suisse upgraded Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) from Neutral to Outperform. The price target for Ollie's Bargain Outlet is set to $20. Ollie's Bargain Outlet shares closed at $16.08 on Thursday.Analysts at Goldman Sachs upgraded Finish Line Inc (NASDAQ: FINL) from Sell to Neutral. The price target for Finish Line is set to $20. Finish Line shares closed at $18.92 on Thursday.Analysts at Morgan Stanley upgraded Pfizer Inc. (NYSE: PFE) from Equal-weight to Overweight. The price target for Pfizer has been raised from $35 to $38. Pfizer shares closed at $31.84 on Thursday.UBS upgraded BlackRock, Inc.

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.

(NYSE: BLK) from Neutral to Buy. The price target for BlackRock has been lowered from $370 to $350. BlackRock shares closed at $295.92 on Thursday.Analysts at Longbow Research upgraded

Martin Marietta Materials, Inc. (NYSE: MLM) from undefined to Buy. Martin Marietta Materials shares closed at $156.72 on Thursday.Analysts at Oppenheimer upgraded Google Inc (NASDAQ: GOOG) from Perform to Outperform. The price target for Google has been raised from $670 to $700. Google shares closed at $611.29 on Thursday.UBS upgraded Northern Trust Corporation (NASDAQ: NTRS) from Sell to Neutral. Northern Trust shares closed at $68.21 on Thursday.Morgan Stanley upgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) from Equal-weight to Overweight. The price target for Alexion Pharmaceuticals has been raised from $186 to $211. Alexion Pharmaceuticals shares closed at $157.82 on Thursday.Goldman Sachs upgraded Summit Materials Inc (NYSE: SUM) from Neutral to Buy. The price target for Summit Materials is set to $29. Summit Materials shares closed at $19.68 on Thursday.